Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 7/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 6/20 | 0.43 |
| ▸ | CA1 | P00915 | 6/20 | 0.43 |
| ▸ | CA4 | P22748 | 2/20 | 0.43 |
| ▸ | CA5A | P35218 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | P4HB | P07237 | 1/20 | 0.41 |
| ▸ | PDIA4 | P13667 | 1/20 | 0.41 |
| ▸ | PDIA3 | P30101 | 1/20 | 0.41 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25346209 | 1.00 | THRB (0.46) | THRBCYP2D6HSD17B10CA2LMNA | |
| SCHEMBL16392960 | 1.00 | THRB (0.46) | THRBCYP2D6HSD17B10CA2LMNA | |
| SCHEMBL5973544 | 0.93 | THRB (0.45) | THRBCYP2D6HSD17B10CA2LMNA | |
| SCHEMBL18349742 | 0.91 | THRB (0.42) | THRBCYP2D6HSD17B10CA2LMNA | |
| SCHEMBL1971892 | 0.90 | THRB (0.40) | THRBCYP2D6HSD17B10CA2LMNA | |
| SCHEMBL16392969 | 0.88 | TSHR (0.42) | THRBCYP2D6HSD17B10CA2LMNA | |
| SCHEMBL22559758 | 0.84 | TSHR (0.39) | THRBCYP2D6HSD17B10CA2LMNA | |
| SCHEMBL16392956 | 0.84 | TSHR (0.39) | THRBCYP2D6HSD17B10CA2LMNA | |
| SCHEMBL30180532 | 0.84 | TSHR (0.39) | THRBCYP2D6HSD17B10CA2LMNA | |
| SCHEMBL25985225 | 0.84 | TSHR (0.39) | THRBCYP2D6HSD17B10CA2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0970114-B1 | NEOGLYCOPROTEINS | NOVARTIS AG (CH) | 2006-07-12 | — | — | EP | disclosed |
| US-6723831-B2 | REMOVAL ANTIBODIES FROM BODY FLUIDS | NOVARTIS AG (CH) | 2004-04-20 | — | — | US | disclosed |
| US-20020164347-A1 | Neoglycoproteins | DUTHALER RUDOLF (CH) | 2002-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020164347-A1 | Neoglycoproteins | CD68, DNPEP, LNPEP | THRB 3538/4885CYP2D6 4427/4885HSD17B10 4329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.